SLC1A2 and nervous system disorder: TGF-α can alleviate neuroexcitotoxicity and protect neuronal cells from damage by regulating glutamate transporter-1 (GLT-1), presenting a potential novel pharmacological target for the treatment of neurological disorders (43, 44).